Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$62.3K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Jun 10 | OFIX | Orthofix Medical Inc. | AGRANT | 14,965 | — | — | +52.8% | Open the original filing on SEC.gov |
| Mar 10 | OFIX | Orthofix Medical Inc. | PBUY | 2,400 | $12.45 | $29.9K | +9.5% | Open the original filing on SEC.gov |
| Mar 10 | OFIX | Orthofix Medical Inc. | PBUY | 100 | $12.44 | $1.2K | +0.4% | Open the original filing on SEC.gov |
| Mar 9 | OFIX | Orthofix Medical Inc. | PBUY | 2,500 | $12.48 | $31.2K | +11.1% | Open the original filing on SEC.gov |
| Aug 14, 2025 | AMED | Amedisys INC | DTOISS | 9,818 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jun 18, 2025 | OFIX | Orthofix Medical Inc. | AGRANT | 18,841 | — | — | +609.1% | Open the original filing on SEC.gov |
| Jun 11, 2025 | JANX | Janux Therapeutics, Inc. | AGRANT◆ | 11,667 | — | — | — | Open the original filing on SEC.gov |
| Jun 11, 2025 | JANX | Janux Therapeutics, Inc. | AGRANT | 3,750 | — | — | +5.3% | Open the original filing on SEC.gov |
| May 3, 2025 | AMED | Amedisys INC | AGRANT | 1,690 | — | — | +20.8% | Open the original filing on SEC.gov |